| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/16/2006 | CA2579652A1 Culturing human embryonic stem cells |
| 03/16/2006 | CA2579551A1 Transglutaminase crosslinked collagen biomaterial for medical implant materials |
| 03/16/2006 | CA2578815A1 Conditioned medium of autologous or allogenic progenitor cells for angiogenesis treatment |
| 03/16/2006 | CA2578750A1 A valacyclovir impurity, process for the preparation of valacyclovir impurity and use as a reference standard |
| 03/16/2006 | CA2578685A1 Method for preparing conditioned medium of astrocyte-like cells |
| 03/16/2006 | CA2578052A1 Methods of activating nkt cells |
| 03/16/2006 | CA2557356A1 Lipases and methods of use |
| 03/15/2006 | EP1634955A1 Conditional gene vectors regulated in cis |
| 03/15/2006 | EP1634954A1 Protease, dna coding for the protease and process for producing the protease |
| 03/15/2006 | EP1634953A2 Platelet-activating factor acethylhydrolase |
| 03/15/2006 | EP1634951A1 Novel protein |
| 03/15/2006 | EP1634949A1 Method for generating activated T-cells and antigen-pulsed antigen-presenting cells |
| 03/15/2006 | EP1634892A2 Composition and methods for the diagnosis of tumours |
| 03/15/2006 | EP1634077A2 Micropositioning cells for tissue engineering |
| 03/15/2006 | EP1633877A1 Flavivirus replicon packaging system |
| 03/15/2006 | EP1633862A2 Method for production of c30-aldehyde carotenoids |
| 03/15/2006 | EP1633860A2 IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA |
| 03/15/2006 | EP1633859A2 Cell line and uses thereof |
| 03/15/2006 | EP1633858A2 Room temperature storage of organs |
| 03/15/2006 | EP1633769A1 Novel transcription factor, bp1 |
| 03/15/2006 | EP1633768A2 Diagnostic and therapeutic treatments related to mitochondrial disorders |
| 03/15/2006 | EP1633399A2 Recombinant antibodies and compositions and methods for making and using the same |
| 03/15/2006 | EP1633316A2 Antibodies that immunospecifically bind to trail receptors |
| 03/15/2006 | EP1633311A2 Compositions and methods for modulating s-nitrosoglutathione reductase |
| 03/15/2006 | EP1633308A2 Hiv-1 envelope glycoproteins having unusual disulfide structure |
| 03/15/2006 | EP1572983A4 Culture chamber for biologicals |
| 03/15/2006 | EP1470155B1 Pluripotency determining factor and uses thereof |
| 03/15/2006 | EP1417300B1 Process for the maturation of dentritic cells and a vaccine |
| 03/15/2006 | EP1343879A4 Methods for isolating novel antimicrobial agents from hypermutable mammalian cells |
| 03/15/2006 | EP1294893B1 Modification of hepatitis b core antigen |
| 03/15/2006 | EP1294864B1 Mutated furin polypeptides having improved characteristics |
| 03/15/2006 | EP1246905B1 Histone deacetylase-8 proteins, nucleic acids, and methods of use |
| 03/15/2006 | EP1233783B9 Hbv/hcv virus-like particle |
| 03/15/2006 | EP1207961B1 Methods of modification of selected cells in a magnetic cell separation column |
| 03/15/2006 | EP1068315B1 Therapeutic agent for ngf |
| 03/15/2006 | EP1045914B1 Testis-specific human svph1-8 proteinase |
| 03/15/2006 | EP1007628B1 Transgenic model for heart failure |
| 03/15/2006 | EP0942973B1 Mutants of the lag-3 proteins, products for the expression of these mutants and use |
| 03/15/2006 | EP0935658B1 Genetic control of flowering |
| 03/15/2006 | EP0929686B1 Early seed 5' regulatory sequence |
| 03/15/2006 | EP0892849B1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 03/15/2006 | EP0870049B1 Complementary adenoviral vector systems and cell lines |
| 03/15/2006 | EP0826035B1 Isolating and culturing schwann cells |
| 03/15/2006 | EP0797436B1 Novel adenoviral vectors, packaging cell lines, recombinant adenoviruses and methods |
| 03/15/2006 | CN1748144A Device and method for non-invasive measurement of the individual metabolic rate of a substantially spherical metabolizing particle |
| 03/15/2006 | CN1748034A Improved genetic elements providing high levels of expression |
| 03/15/2006 | CN1748033A Method for modifying plant growth characteristics |
| 03/15/2006 | CN1748025A Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same |
| 03/15/2006 | CN1747971A Antibody ('11c7') anti nogo a and its pharmaceutical use |
| 03/15/2006 | CN1747753A Cell sheets for ectocornea formation, method of producing the same and method of using the same |
| 03/15/2006 | CN1747744A Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene |
| 03/15/2006 | CN1747651A Hybrid cotton plants and seeds, and methods and systems of generating same |
| 03/15/2006 | CN1746307A Transcription factor gene of cold-resisting and salt tolerant code regulated lawn plants |
| 03/15/2006 | CN1746297A Placenta source filling dry cell and production thereof |
| 03/15/2006 | CN1746296A Tissue engineering bone based on placenta source filling dry cell and production thereof |
| 03/15/2006 | CN1746295A Tissue engineering cartilage based on placenta source filling dry cell and production thereof |
| 03/15/2006 | CN1746294A Method for setting up matured embryo regenerating system of zhonghuajielu grass |
| 03/15/2006 | CN1745735A Automatic clinical biological cell therapeutical system |
| 03/15/2006 | CN1745626A Modified cell line of male mammal, its production and use thereof |
| 03/15/2006 | CN1245516C Gene encoding acetolactic acid sy nthase gene |
| 03/15/2006 | CN1245513C Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and ctenocephalides spp |
| 03/15/2006 | CN1245511C Anhydrant gene BcDh1 and the application of its promoter in raising drought-enduring plant |
| 03/15/2006 | CN1245504C CIK cell external culturing method |
| 03/14/2006 | USRE39015 Recombinant polynucleotide or expression vector encoding an antigenic protein, cytokines, antibodies, fusion proteins; open reading frame; isolate host cell; control immune system |
| 03/14/2006 | US7013219 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 03/14/2006 | US7012177 Inbred corn line PH714 |
| 03/14/2006 | US7012176 Corn hybrid seeds and plants with superior characteristics |
| 03/14/2006 | US7012171 Plant cell is transformed with a chimaeric gene containin a promoter and a gene encoding a polypeptide which displays the activity of an enzyme which regulates the amount of a metabolic intermediate in glycolysis |
| 03/14/2006 | US7012133 Antibodies to C-C chemokine Receptor 3 Protein |
| 03/14/2006 | US7012132 Modified factor VIII |
| 03/14/2006 | US7011976 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| 03/14/2006 | US7011974 Using hybridomas cells; gene expression; monoclonal antibodies |
| 03/14/2006 | US7011973 recombinant DNA molecules comprising regulatory sequences of an intron of the Vascular Endothelial Growth Factor receptor-2 gene or of a gene homologous to the Flk-1 gene, being capable of conferring expression of a heterologous DNA sequence |
| 03/14/2006 | US7011972 Fusion polypeptide comprising two ligand binding domains |
| 03/14/2006 | US7011967 Seripancrin |
| 03/14/2006 | US7011959 polyketide synthesized by either a modular, iterative, or fungal PKS; precursor is selected from malonyl CoA, propionyl CoA, methylmalonyl CoA, ethylmalonyl CoA, and hydroxymalonyl or methoxymalonyl CoA |
| 03/14/2006 | US7011938 Determining Mean Platelet Component of suspended blood platelets, using an anticoagulant composed of a component for effecting platelet sphering, and at least a platelet antagonist. |
| 03/14/2006 | US7011852 Separation of platelets from whole blood for use as a healant |
| 03/14/2006 | US7011828 Regeneration cells of nervous system |
| 03/14/2006 | US7011827 Compositions and methods for producing and using homogenous neuronal cell transplants |
| 03/14/2006 | US7011623 Ex vivo remodeling of excised blood vessels for vascular grafts |
| 03/14/2006 | CA2291932C A method for producing the transformants of coffee plants and transgenic coffee plants |
| 03/14/2006 | CA2154854C Immortalized lymphocytes for production of viral-free proteins |
| 03/09/2006 | WO2006026746A2 Methods to separate and expand antigen-specific t cells |
| 03/09/2006 | WO2006026570A2 Use of stem cells to generate inner ear cells |
| 03/09/2006 | WO2006026473A2 METHODS AND COMPOSITIONS UTILIZING MYC AND GSK3ß TO MANIPULATE THE PLURIPOTENCY OF EMBRYONIC STEM CELLS |
| 03/09/2006 | WO2006026445A1 Production of polypeptides |
| 03/09/2006 | WO2006025937A2 Embryonic stem cell derivatives, and methods of making and using the same |
| 03/09/2006 | WO2006025802A1 Method for maintaining pluripotency of stem/progenitor cells |
| 03/09/2006 | WO2006025580A1 Anti-histone h1 monoclonal antibody and hybridoma capable of producing the same |
| 03/09/2006 | WO2006025526A1 Process for producing dendritic cell having acquired ctl inducing capability |
| 03/09/2006 | WO2006025525A1 Method of selecting protein easily undergoing antigen-presentation by dendritic cells |
| 03/09/2006 | WO2006025443A1 Genetically modified plant proudcing lactosyl ceramide and utilization of the same |
| 03/09/2006 | WO2006024966A2 Three-dimensional self assembly in suspension of adherent cells |
| 03/09/2006 | WO2006024947A2 Methods and materials relating to enhanced production of dopamine neurons |
| 03/09/2006 | WO2006024856A1 Jaw bone augmentation using tooth primordium |
| 03/09/2006 | WO2006024769A1 Use of dendrimers to stimulate cell growth |
| 03/09/2006 | WO2006015304A3 Amorphous cell delivery vehicle treated with physical/physicochemical stimuli |
| 03/09/2006 | WO2006007377A9 Methods of screening for bridge-1-mediated disorders, including type ii diabetes |
| 03/09/2006 | WO2006004878A9 Attenuated herpes simplex virus type-2, vectors thereof and immunogenic compositions thereof |